Abstract
Type I Interferon Signaling Contributes to Antitumor Immune Response and is Reduced by Imatinib in Gastrointestinal Stromal Tumor (GIST)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have